Message #12 From:
NewsBot Date: November 1, 2005 02:00:00 AM
DUSA News DUSA Pharmaceuticals, Inc. to Host Third Quarter 2005 Corporate Highlights and Financial Results Conference Call
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 1, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that its third quarter corporate highlights and financial results press release will be issued on Friday, November 4th, 2005 at 7:00 a.m. to be followed by a conference call at 8:45 a.m.
Friday, November 4th, 8:45 a.m. Eastern
If calling from the US or Canada use the following toll-free number:
800.936.4602
Password - DUSA
For International callers use
507.726.3418
Password - DUSA
A recorded replay of the call will be available by 12:00 pm
North American callers 800.334.2128
International callers 580.431.2986
The call will be accessible on our web site after 1:00 p.m. www.dusapharma.com.
DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of Levulan(R) Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with its primary focus in dermatology. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA maintains offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.
